Differences in ocular surface irritation between timolol hemihydrate and timolol maleate

American Journal of Ophthalmology

Volumn 130, Issue 6, 2000, Pages 712-716

  Stewart, William C ^a,b   Stewart, Jeanette A ^a   Holmes, Keri T ^a   Leech, Jessica N ^a  

^a University of South Carolina   (United States)

^b UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TIMOLOL; TIMOLOL MALEATE;

ADULT; ARTICLE; CLINICAL TRIAL; CONJUNCTIVA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORNEA; DRY EYE; EYE IRRITATION; FATIGUE; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; NOSE; PHOTOPHOBIA; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL;

ADRENERGIC BETA-ANTAGONISTS; ADULT; CONJUNCTIVA; CORNEA; DOUBLE-BLIND METHOD; DRUG EVALUATION; EPITHELIUM; FEMALE; HUMANS; IRRITANTS; MALE; OPHTHALMIC SOLUTIONS; SAFETY; TIMOLOL;

EID: 0034535964     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(00)00611-5     Document Type: Article

References (19)

1. Dubiner HB, Hill R, Kaufman H, et al. Timolol hemihydrate vs. timolol maleate in ocular hypertension and open-angle glaucoma. Am J Ophthalmol 1996;121:522-528.
2. Stewart WC. Timolol hemihydrate - a new formulation of timolol for the treatment of glaucoma. J Ocul Pharmacol 1995;12:225-237.
3. Rosner B. Fundamentals of biostatistics. Boston: Duxbury Press, 1982:301-304.
4. Siegel S. Nonparametric statistics. Series in Psychology. New York: McGraw Hill, 1956:63-67.
5. Zucker JL. Eyelid disorders: recognizing pathologic changes in the older patient. Geriatrics 1993;48:56-58.
6. Roy H, Tindall R. An update on the use of drugs for common eye problems in older patients. Geriatrics 1991;46:51-54.
7. Herreras JM, Pastor C, Calonge M, Asensio VM. Ocular surface alteration after long-term treatment with an antiglaucomatous drug. Ophthalmology 1992;99:1082-1088.
8. Bradway D, Grierson I, Hitchings R. Adverse effects of topical antiglaucomatous medications on the conjunctiva. Br J Ophthalmol 1993;77:590-596.
9. Adkins JC, Balfour JA. Brimonidine. A review of its pharmacological properties and clinical potential in the management of open-angle glaucoma and ocular hypertension. Drugs Aging 1998;12:225-241.
10. Levrat F, Pisella PJ, Baudouin C. Clinical tolerance of anti-glaucoma eyedrops with and without a preservative. Results of an unpublished survey in Europe. J Fr Ophthalmol 1999;22:186-191.
11. De Jong C, Stolwijk T, Kuppens E, de Keizer R, van Best J. Topical timolol with and without benzalkonium chloride: epithelial permeability and autoflorescence of the cornea in glaucoma. Graefes Arch Clin Exp Ophthalmol 1994;232: 221-224.
12. Kuppens EV, de Jong CA, Stolwijk TR, de Keizer RJ, van Best JA. Effect of timolol with and without preservative on the basal tear turnover in glaucoma. Br J Ophthalmol 1995;79:339-342.
13. Verani RR, Brewer ED, Ince A, Gibson J, Bulger RE. Proximal tubular necrosis with maleic acid administration to the rat. Lab Invest 1982;46:79-88.
14. Megaw JM. Glutathione and ocular photobiology. Curr Eye Res 1984;3:83-87.
15. Riley MV. Physiological neutralization mechanisms and the response of the corneal endothelium to hydrogen peroxide. CLAO J 1990;16:S16-S21.
16. Atalla LR, Sevanian A, Rao NA. Immunohistochemical localization of glutathione peroxidase in ocular tissue. Curr Eye Res 1988;7:1023-1027.
17. Gerard-Monnier D, Fougeat S, Gourvest JF, Chaudiere J. Partial prevention of glutathione depletion in rats following acute intoxication with diethylmaleate. Clin Physiol Biochem 1993;10:36.
18. Stewart WC, Dubiner HB, Mundorf TK, et al. Effects of carteolol and timolol on plasma lipid profiles in older women with ocular hypertension or primary open angle glaucoma. Am J Ophthalmol 1999;127:142-147.
19. Stewart WC, Cohen JS, Netland PA, Weiss H, and the Nocturnal Investigation of Glaucoma Hemodynamics Trial Study Group. Efficacy of carteolol 1% vs. timolol maleate 0.5% in subjects with elevated intraocular pressure. Am J Ophthalmol 1997;124:498-505.